你即將離開本站

並前往https://www.drugtopics.com/view/asco-2021-parp-inhibitor-improves-disease-free-survival-in-high-risk-early-breast-cancer

ASCO 2021: PARP Inhibitor Improves Disease-Free Survival ...

... study evaluating olaparib as adjuvant therapy in high-risk early-stage breast cancer therapy were presented at the 2021 ASCO Annual Meeting.

確定！ 回上一頁

查詢 「asco 2021」的人也找了：

  1. ASCO 2021 Abstract
    2.
  2. asco年會
    3.
  3. ASCO 2020
    4.
  4. ESMO 2021
    5.
  5. ASCO 2022
    6.
  6. ASCO GI 2021
    7.
  7. ASCO 2021 virtual Meeting
    8.
  8. ASCO 2021 registration
    9.